FDG PET/CT in monitoring treatment of retroperitoneal fibrosis


Yilmaz S., Tan Y. Z. , Ozhan M., Halac M., Asa S., Sonmezoglu K.

REVISTA ESPANOLA DE MEDICINA NUCLEAR E IMAGEN MOLECULAR, vol.31, no.6, pp.338-339, 2012 (Journal Indexed in SCI) identifier identifier identifier

Abstract

Retroperitoneal fibrosis is an uncommon disease characterized by inflammatory fibrosis typically surrounding abdominal aorta and iliac arteries. The glucose analogue F18-fluorodeoxyglucose can be used to image inflammatory cell activity non-invasively by PET. In this report we investigated the usefulness of the FDG PET/CT in the disease activity and therapy response evaluation of retroperitoneal fibrosis. (C) 2012 Elsevier Espana, S.L. and SEMNIM. All rights reserved.